152 related articles for article (PubMed ID: 12199802)
21. Autoimmune hemolytic anaemia in the antiphospholipid syndrome.
Rottem M; Krause I; Fraser A; Stojanovich L; Rovensky J; Shoenfeld Y
Lupus; 2006; 15(7):473-7. PubMed ID: 16898185
[TBL] [Abstract][Full Text] [Related]
22. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
Ungprasert P; Tanratana P; Srivali N
Thromb Res; 2015 Nov; 136(5):1013-7. PubMed ID: 26359320
[TBL] [Abstract][Full Text] [Related]
24. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
25. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
26. Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant.
Pengo V; Testa S; Martinelli I; Ghirarduzzi A; Legnani C; Gresele P; Passamonti SM; Bison E; Denas G; Jose SP; Banzato A; Ruffatti A
Thromb Res; 2015 Jan; 135(1):46-9. PubMed ID: 25456002
[TBL] [Abstract][Full Text] [Related]
27. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
28. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia.
Giordano P; Galli M; Del Vecchio GC; Altomare M; Norbis F; Ruggeri L; Petronelli M; de Mattia D
Br J Haematol; 1998 Sep; 102(4):903-6. PubMed ID: 9734637
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
Barbui T; Finazzi G; Galli M
Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
[TBL] [Abstract][Full Text] [Related]
30. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus.
Lang B; Straub RH; Weber S; Röther E; Fleck M; Peter HH
Lupus; 1997; 6(8):652-5. PubMed ID: 9364424
[TBL] [Abstract][Full Text] [Related]
31. Can Biomarkers of Coagulation, Platelet Activation, and Inflammation Predict Venous Thromboembolism in Patients with Haematological Malignancies?
Elmoamly S; Mattar M; Yacoub MF; Afif A
Acta Haematol; 2019; 141(4):245-253. PubMed ID: 30965330
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
[TBL] [Abstract][Full Text] [Related]
33. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism.
Pasquier E; Amiral J; de Saint Martin L; Mottier D
Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
35. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
[TBL] [Abstract][Full Text] [Related]
36. Multiple autoantibody production in a patient with splenic lymphoma.
Sawamura M; Yamaguchi S; Murakami H; Amagai H; Matsushima T; Tamura J; Naruse T; Tsuchiya J
Ann Hematol; 1994 May; 68(5):251-4. PubMed ID: 8018767
[TBL] [Abstract][Full Text] [Related]
37. Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study.
Schär DT; Daskalakis M; Mansouri B; Rovo A; Zeerleder S
Eur J Haematol; 2022 Jan; 108(1):45-51. PubMed ID: 34551149
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of antiphospholipid syndrome.
Bertolaccini ML; Khamashta MA
Expert Rev Hematol; 2008 Dec; 1(2):183-8. PubMed ID: 21082923
[TBL] [Abstract][Full Text] [Related]
39. Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major.
Sharma S; Raina V; Chandra J; Narayan S; Sharma S
Hematology; 2006 Aug; 11(4):287-90. PubMed ID: 17178669
[TBL] [Abstract][Full Text] [Related]
40. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
